Rise Advisors’s Axcelis ACLS Stock Holding History

Rise Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22	Closed	-$2.15K	–	112
2025 Q3	$2.15K	Hold	22	–	–	﹤0.01%	1187
2025 Q2	$1.53K	Buy	22 +14	+175%	+$799	﹤0.01%	1224
2025 Q1	$397	Buy	+8	New	+$506	﹤0.01%	1406

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Rise Advisors's ACLS Position: Q4 2025 in Review

Rise Advisors sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 22 shares — an estimated $2.15K sold.

Rise Advisors first reported a position in ACLS in Q1 2025 and held it in 3 quarters. The position peaked at $2.15K in Q3 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

Rise Advisors reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 22 Axcelis shares in Q4 2025, an estimated $2.15K.
Rise Advisors first reported a position in Axcelis in Q1 2025 and held it in 3 quarters.
Rise Advisors's Axcelis position peaked at $2.15K in Q3 2025.
370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.